Effect on Primary Dysmenorrhea

• Status: Completed
• Trial end date: 2010-11-01

Summary

To investigate the potential benefits of a new oral contraceptive (SH T00658ID) on alleviating complaints of dysmenorrhea associated with oral contraceptive use.

• Phase: Phase 3

Details

• Lead Sponsor: Bayer
• Treatments: Dienogest; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Ethinyl Estradiol; Levonorgestrel; Polyestradiol phosphate